Pharma Co. Chiasma To Settle Investors' IPO Suit For $18.7M
By John Petrick ( March 1, 2019, 8:45 PM EST) -- Biopharmaceutical company Chiasma and a proposed class of shareholders asked a Massachusetts judge for preliminary approval Friday of an $18.75 million settlement over claims the company misled prospective investors in its initial public offering about the chances of a new drug getting regulatory approval....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.